|
2383-2386
Reversible Carnitine Palmitoyltransferase Inhibitors with Broad Chemical Diversity as Potential Antidiabetic Agents
Fabio Giannessi,
Piero Chiodi,
Mauro Marzi,
Patrizia Minetti,
Pompeo Pessotto,
Francesco De Angelis,
Emanuela Tassoni,
Roberto Conti,
Fabrizio Giorgi,
Massimo Mabilia,
Natalina Dell'Uomo,
Sandra Muck,
Maria O. Tinti,
Paolo Carminati, and
Arduino Arduini
[Full Article -
PDF]
| |
2387-2390
Novel C-Terminus Modifications of the Dmt-Tic Motif: A New Class of Dipeptide Analogues Showing Altered Pharmacological Profiles Toward the Opioid Receptors
Daniel Pagé,
Angela Naismith,
Ralf Schmidt,
Martin Coupal,
Maryse Labarre,
Mylène Gosselin,
Daniel Bellemare,
Kemal Payza, and
William Brown
[Full Article -
PDF]
| |
|
2391-2402
Design, Synthesis, Computational Prediction, and Biological Evaluation of Ester Soft Drugs as Inhibitors of Dihydrofolate Reductase from Pneumocystis carinii
Malin Graffner-Nordberg,
Karin Kolmodin,
Johan Åqvist,
Sherry F. Queener, and
Anders Hallberg
[Full Article -
PDF]
| |
2403-2410
Phenylpiperazinylalkylamino Substituted Pyridazinones as Potent 1 Adrenoceptor Antagonists
Daniela Barlocco,
Giorgio Cignarella,
Vittorio Dal Piaz,
M. Paola Giovannoni,
Pier G. De Benedetti,
Francesca Fanelli,
Federica Montesano,
Elena Poggesi, and
Amedeo Leonardi
[Full Article -
PDF]
| |
2411-2420
Volume Learning Algorithm Artificial Neural Networks for 3D QSAR Studies
Igor V. Tetko,
Vasyl V. Kovalishyn, and
David J. Livingstone
[Full Article -
PDF]
| |
2421-2431
Nonpeptidic, Monocharged, Cell Permeable Ligands for the p56lck SH2 Domain
John R. Proudfoot,
Rajashehar Betageri,
Mario Cardozo,
Thomas A. Gilmore,
Susan Glynn,
Eugene R. Hickey,
Scott Jakes,
Alisa Kabcenell,
Thomas M. Kirrane,
Annette K. Tibolla,
Susan Lukas,
Usha R. Patel,
Rajiv Sharma,
Mehran Yazdanian, and
Neil Moss
, Pierre L. Beaulieu,
Dale R. Cameron,
Jean-Marie Ferland,
Jean Gauthier,
James Gillard,
Vida Gorys,
Martin Poirier,
Jean Rancourt,
Dominik Wernic, and
Montse Llinas-Brunet
[Full Article -
PDF]
| |
2432-2437
Discriminating between Drugs and Nondrugs by Prediction of Activity Spectra for Substances (PASS)
Soheila Anzali,
Gerhard Barnickel,
Bertram Cezanne,
Michael Krug,
Dmitrii Filimonov, and
Vladimir Poroikov
[Full Article -
PDF]
| |
2438-2450
Potent Dibasic GPIIb/IIIa Antagonists with Reduced Prolongation of Bleeding Time: Synthesis and Pharmacological Evaluation of 2-Oxopiperazine Derivatives
Shuji Kitamura,
Hideto Fukushi,
Toshio Miyawaki,
Masaki Kawamura,
Noriko Konishi,
Zen-ichi Terashita, and
Takehiko Naka
[Full Article -
PDF]
| |
2451-2459
Synthesis and Evaluation of Hydroxylated Polyamine Analogues as Antiproliferatives
Raymond J. Bergeron,
Ralf Müller,
Guangfei Huang,
James S. McManis,
Samuel E. Algee,
Hua Yao,
William R. Weimar, and
Jan Wiegand
[Full Article -
PDF]
| |
2460-2468
Peptide Folding Induces High and Selective Affinity of a Linear and Small -Peptide to the Human Somatostatin Receptor 4
Karl Gademann,
Thierry Kimmerlin,
Daniel Hoyer, and
Dieter Seebach
[Full Article -
PDF]
| |
2469-2478
Significance of Asymmetric Sites in Choosing Siderophores as Deferration Agents
Raymond J. Bergeron,
Mei Guo Xin,
William R. Weimar,
Richard E. Smith, and
Jan Wiegand
[Full Article -
PDF]
| |
2479-2485
Bisubstrate Ketone Analogues as Serotonin N-Acetyltransferase Inhibitors
Cheol Min Kim and
Philip A. Cole
[Full Article -
PDF]
| |
2486-2489
Preparation and Cytotoxicity toward Cancer Cells of Mono(arylimino) Derivatives of -Lapachone
Pablo H. Di Chenna,
Violeta Benedetti-Doctorovich,
Ricardo F. Baggio,
M. Teresa Garland, and
Gerardo Burton
[Full Article -
PDF]
| |
2490-2497
ElogDoct: A Tool for Lipophilicity Determination in Drug Discovery. 2. Basic and Neutral Compounds
Franco Lombardo,
Marina Y. Shalaeva,
Karl A. Tupper, and
Feng Gao
[Full Article -
PDF]
| |